Mitochondria play a fundamental role in plenty of cellular metabolic processes, and mitochondria-homing drug delivery is a promising and effective strategy for cancer treatment. Paclitaxel (PTX) is a broad-spectrum anticancer drug, but its therapeutic effect is highly limited due to the development of multidrug resistance. Berberine (BBR) can selectively accumulate in tumor cell mitochondria and inhibit the growth of cancer cells with different biological action mechanism from PTX. Here, these two "old" drug molecules, BBR and PTX were linked together by a disulfide bond rope to construct GSH-responsible drug-drug conjugate (PTX-ss-BBR). Molecular dynamics simulation results revealed that PTX-ss-BBR conjugate could be self-assembled in water to form nanoparticles (PTX-ss-BBR NPs) forced by π-π stacking and hydrophobic interactions and the average size of NPs was around 165 nm measured by DLS. The better in vitro potency of PTX-ss-BBR NPs against A549 cells might be ascribed to the simultaneous drug release and mitochondria-targeting delivery, which dissipated mitochondria membrane potential, upregulated ROS levels in cancer cells, arrested cells in phase G2/M, elicited apoptosis of cancer cells and inhibited the growth of tumors. Furthermore, PTX-ss-BBR NPs also exerted efficacy better than or comparable to BBR on S. aureus and E. coli, which were closely associated with the development of lung cancer. The synergistic effect of PTX and BBR enhanced the treatment effect of conventional chemotherapy drugs against A549 cells.
Keywords: Berberine; Mitochondria-targeting; Paclitaxel; Self-assembled nanomedicine.
Copyright © 2019 Elsevier B.V. All rights reserved.
Novel Free-Paclitaxel-Loaded Redox-Responsive Nanoparticles Based on a Disulfide-Linked Poly(ethylene Glycol)-Drug Conjugate for Intracellular Drug Delivery: Synthesis, Characterization, and Antitumor Activity in Vitro and in VivoX Chuan et al. Mol Pharm 11 (10), 3656-70. PMID 25208098.To address the obstacles facing cancer chemotherapeutics, including toxicity, side effects, water insolubility, and lack of tumor selectivity, a novel stimuli-responsive …
Delivery of Baicalein and Paclitaxel Using Self-Assembled Nanoparticles: Synergistic Antitumor Effect in Vitro and in VivoW Wang et al. Int J Nanomedicine 10, 3737-50. PMID 26045664.The prepared PTX-BCL NP drug-delivery system was proven efficient by its targeting of drug-resistant human lung cancer cells and delivering of BCL and PTX prodrugs. Enhan …
Intracellular Delivery and Antitumor Effects of a Redox-Responsive Polymeric Paclitaxel Conjugate Based on Hyaluronic AcidS Yin et al. Acta Biomater 26, 274-85. PMID 26300335.Polymer-drug conjugates, promising nanomedicines, still face some technical challenges including a lack of specific targeting and rapid intracellular drug release at the …
pH and Redox Dual-Responsive Copolymer Micelles With Surface Charge Reversal for Co-Delivery of All- trans-retinoic Acid and Paclitaxel for Cancer Combination ChemotherapyY Zhang et al. Int J Nanomedicine 13, 6499-6515. PMID 30410335.The charge-reversal and GSH-responsive DA-ss-NPs provide an excellent platform for potential tumor therapy.
α-Amylase- And Redox-Responsive Nanoparticles for Tumor-Targeted Drug DeliveryY Li et al. ACS Appl Mater Interfaces 9 (22), 19215-19230. PMID 28513132.Paclitaxel (PTX) is an effective antineoplastic agent and shows potent antitumor activity against a wide spectrum of cancers. Yet, the wide clinical use of PTX is limited …